Announcements
- NFL BIOSCIENCES : DÉPÔT D’UNE DEMANDE DE BREVET AUX ÉTATS-UNIS DÉDIÉE À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL AVEC NFL-301 & PRÉPARATION D’UNE DEMANDE DE PRE-IND AUPRÈS DE LA FDA
- Nfl Biosciences: Patent Application Filed in the United States for Reducing Alcohol Consumption With Nfl-301 & Preparation of a Pre-Ind Application Submission With the Fda
- NFL BIOSCIENCES CONFIRME LE RENOUVELLEMENT DE SON ELIGIBILITE AU PEA-PME
- BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ : 1er SEMESTRE 2023
- NFL BIOSCIENCES: CO-FOUNDER SHAREHOLDER FURTHER STRENGTHENS HIS POSITION BY EXERCISING “BSPCE” WARRANTS
- NFL BIOSCIENCES : RENFORCEMENT D’UN ACTIONNAIRE FONDATEUR PAR EXERCICE DE BSPCE
- NFL BIOSCIENCES : MONTÉE AU CAPITAL DE GB HOLDING PAR EXERCICE DE BSA POUR 0,5 M€ ET ENGAGEMENT DE CONSERVATION D’ACTIONS
- NFL BIOSCIENCES: GB HOLDING TAKES A STAKE IN THE COMPANY’S CAPITAL UPON THE EXERCISE OF SHARE SUBSCRIPTION WARRANTS AND PAYMENT OF 0.5M€, AND ALSO COMMITS TO A LOCK-UP
- NFL BIOSCIENCES : RESULTS OF THE COMBINED GENERAL MEETING OF JUNE 27, 2023
- NFL BIOSCIENCES : COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 27 JUIN 2023
More ▼
Key statistics
As of last trade Nfl Biosciences SAS (82F:FRA) traded at 2.33, -25.24% below its 52-week high of 3.11, set on Jun 21, 2023.
52-week range
Open | 2.33 |
---|---|
High | 2.33 |
Low | 2.33 |
Bid | 2.28 |
Offer | 2.39 |
Previous close | 2.41 |
Average volume | 0.00 |
---|---|
Shares outstanding | 9.71m |
Free float | 7.28m |
P/E (TTM) | -- |
Market cap | 24.46m EUR |
EPS (TTM) | -0.5396 EUR |
Data delayed at least 15 minutes, as of Jun 13 2024 07:12 BST.
More ▼